Zalcman, Gérard <br/><br/>
[EGFR pathway and mechanism of action of tyrosine kinase inhibitors].  [electronic resource] 

 -  Revue de pneumologie clinique  Jan 2007 
 - 2S5-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0761-8417 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bronchial Neoplasms--drug therapy<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chromosomes, Human, Pair 7--genetics<br/>Epidermal Growth Factor--drug effects<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Genes, erbB-2--drug effects<br/>Genes, ras--drug effects<br/>Humans<br/>Mutation<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Quinazolines--pharmacology<br/>Respiratory Mucosa--drug effects